Exhausted <scp>CD8</scp> <sup>+</sup> T Cell in <scp>HIV</scp> Infection Exhibits an Impaired Bioenergetic Metabolism Driven by Mitochondrial Dysfunction
In people living with HIV (PLWH), persistent viral replication and antiretroviral therapy (ART)-associated toxicity contribute to T cell exhaustion, characterised by significant metabolic reprogramming that negatively impacts cellular function and longevity. Understanding the metabolic dysregulation in exhausted T cells could unveil novel therapeutic strategies to rejuvenate immune responses in PLWH. This study investigated the prevalence and metabolic gene expression profiles of exhausted CD8<sup>+</sup> T cells across three PLWH cohorts: viremic treatment-naïve (TN), viremic treatment-failure (TF) and aviremic treatment-responders (TR). Our analysis revealed that the proportion of exhausted CD8<sup>+</sup> T cells (PD1<sup>+</sup>CD107a<sup>-</sup>) was markedly higher in viremic TN (5.1%) and TF (4.2%) groups compared to the aviremic TR cohort (2.2%, p < 0.05). Similarly, the percentage of terminally differentiated T<sub>EMRA</sub> cells (CCR7<sup>-</sup>CD45RA<sup>+</sup>) was elevated in TN (38.0%) and TF (44.7%) compared with TR (21.5%, p < 0.05), indicating a higher prevalence of late-stage differentiation and exhaustion in viremic individuals. NanoString analysis revealed a broad downregulation of metabolic genes in exhausted CD8<sup>+</sup> T cells from viremic individuals, suggesting a shift toward a metabolically quiescent state akin to naïve T cells. Seahorse analysis revealed impaired mitochondrial respiration in CD8<sup>+</sup> T cells from viremic PLWH, characterised by reductions in both ATP-linked respiration and proton leak. Furthermore, we reported that combined treatment with MitoTEMPO and N-acetyl-l-cysteine (NAC) improved mitochondrial function but failed to restore the effector capacity of CD8<sup>+</sup> T cells. In summary, this study highlights the defective metabolic programming of exhausted CD8<sup>+</sup> T cells in viremic PLWH, underscoring potential metabolic targets for therapeutic intervention.
Authors
- Chirk Jenn Ng (ORCID: https://orcid.org/0000-0002-8320-1603)
- Kian‐Kai Cheng (ORCID: https://orcid.org/0000-0002-5894-1781)
- Won Fen Wong (ORCID: https://orcid.org/0000-0003-1082-1956)
- Rong Xiang Ng (ORCID: https://orcid.org/0000-0002-3358-4255)
- Adeeba Kamarulzaman (ORCID: https://orcid.org/0000-0002-8074-4450)
- Alireza Saeidi
- Reena Rajasuriar (ORCID: https://orcid.org/0000-0003-3756-0629)
- Yi Ying Cheok (ORCID: https://orcid.org/0000-0003-4908-5618)
- Chung Yeng Looi (ORCID: https://orcid.org/0000-0002-4830-3495)
- Iskandar Azwa (ORCID: https://orcid.org/0000-0003-1977-6709)
- Heng Choon Cheong (ORCID: https://orcid.org/0000-0002-9279-3591)
- Yee Teng Chan (ORCID: https://orcid.org/0000-0003-1955-1104)
- Kar Min Loh
- Ting Tang (ORCID: https://orcid.org/0009-0004-0981-9626)
- Zhi Ying Phong
Institutions
- Monash University Malaysia (MY)
- University Malaya Medical Centre (MY)
- University of Malaya (MY)
- Taylor's University (MY)
- University of Technology Malaysia (MY)
Publication Details
- Journal
- Immunology
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1111/imm.70054
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00